The Claim
In individuals with no prior vascular disease, statin therapy associated with a 1.0 mmol/L reduction in LDL cholesterol is causally linked to a 12% reduction in vascular mortality and a 9% reduction in all-cause mortality, with no significant increase in non-vascular mortality.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking statins to lower your 'bad' cholesterol by about 1 point (in mmol/L) can cut your risk of dying from heart problems by 12% and your overall risk of dying by 9%, without raising your risk of dying from other causes like cancer or accidents.
See the scientific wording
Statin therapy reduces vascular mortality by 12% per 1.0 mmol/L LDL cholesterol reduction and all-cause mortality by 9% in individuals with no prior vascular disease, with no increase in non-vascular mortality.
Lowering LDL cholesterol stops more fatty deposits from building up inside artery walls, causes existing deposits to become harder and less likely to rupture, and reduces swelling in the artery walls. This prevents blood clots from forming and blocking arteries, which stops heart attacks and strokes, leading to fewer deaths from heart disease and overall death.
What the research says
1 studyTaking statins to lower bad cholesterol by about 1 point reduces the chance of dying from heart problems by about 12% and overall death by 9%, and doesn’t increase the risk of dying from cancer or other causes — exactly what this big study found.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.